These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 23808570)
1. Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum. Zhang B; Zhao Y; Cai Z; Caulloo S; McElwee KJ; Li Y; Chen X; Yu M; Yang J; Chen W; Tang X; Zhang X Australas J Dermatol; 2013 Aug; 54(3):184-91. PubMed ID: 23808570 [TBL] [Abstract][Full Text] [Related]
2. Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata. Zhang X; Zhao Y; Ye Y; Li S; Qi S; Yang Y; Cao H; Yang J; Zhang X Arch Dermatol Res; 2015 May; 307(4):319-31. PubMed ID: 25638328 [TBL] [Abstract][Full Text] [Related]
3. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles. Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575 [TBL] [Abstract][Full Text] [Related]
4. Diffuse alopecia areata is associated with intense inflammatory infiltration and CD8+ T cells in hair loss regions and an increase in serum IgE level. Zhao Y; Zhang B; Caulloo S; Chen X; Li Y; Zhang X Indian J Dermatol Venereol Leprol; 2012; 78(6):709-14. PubMed ID: 23075639 [TBL] [Abstract][Full Text] [Related]
5. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase. Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic usefulness of a peribulbar eosinophilic infiltrate in alopecia areata. Yoon TY; Lee DY; Kim YJ; Lee JY; Kim MK JAMA Dermatol; 2014 Sep; 150(9):952-6. PubMed ID: 24990252 [TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507 [TBL] [Abstract][Full Text] [Related]
8. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss. McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017 [TBL] [Abstract][Full Text] [Related]
9. Non-scarring patchy alopecia in patients with systemic lupus erythematosus differs from that of alopecia areata. Ye Y; Zhao Y; Gong Y; Zhang X; Caulloo S; Zhang B; Cai Z; Yang J; McElwee KJ; Zhang X Lupus; 2013 Dec; 22(14):1439-45. PubMed ID: 24132518 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620 [TBL] [Abstract][Full Text] [Related]
11. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone. Wasyłyszyn T; Kozłowski W; Zabielski SL Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266 [TBL] [Abstract][Full Text] [Related]
12. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166 [TBL] [Abstract][Full Text] [Related]
13. Investigation of the inflammatory mechanisms in alopecia areata. Cetin ED; Savk E; Uslu M; Eskin M; Karul A Am J Dermatopathol; 2009 Feb; 31(1):53-60. PubMed ID: 19155726 [TBL] [Abstract][Full Text] [Related]
14. Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates. Peckham SJ; Sloan SB; Elston DM J Am Acad Dermatol; 2011 Sep; 65(3):615-620. PubMed ID: 21684037 [TBL] [Abstract][Full Text] [Related]
15. No basophil infiltration in alopecia areata irrespective of the intensity of eosinophil infiltration. Ono S; Otsuka A; Miyachi Y; Kabashima K Acta Derm Venereol; 2013 Mar; 93(2):185-6. PubMed ID: 22948616 [No Abstract] [Full Text] [Related]
16. The DEBR rat, alopecia areata and autoantibodies to the hair follicle. McElwee KJ; Pickett P; Oliver RF Br J Dermatol; 1996 Jan; 134(1):55-63. PubMed ID: 8745887 [TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory Vδ1 Uchida Y; Gherardini J; Schulte-Mecklenbeck A; Alam M; Chéret J; Rossi A; Kanekura T; Gross CC; Arakawa A; Gilhar A; Bertolini M; Paus R J Dermatol Sci; 2020 Nov; 100(2):129-138. PubMed ID: 33039243 [TBL] [Abstract][Full Text] [Related]
18. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester. Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465 [TBL] [Abstract][Full Text] [Related]
19. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Gilhar A; Kalish RS Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213 [TBL] [Abstract][Full Text] [Related]
20. Distinguishing diffuse alopecia areata (AA) from pattern hair loss (PHL) using CD3(+) T cells. Kolivras A; Thompson C J Am Acad Dermatol; 2016 May; 74(5):937-44. PubMed ID: 26851831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]